Axogen, Inc. — Director's Dealing 2020

Jan 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2020-01-01

Reporting Person: Rudelius Robert James (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-01	Common Stock	M	13000	$2.75	Acquired	47591	Direct
2020-01-01	Common Stock	F	1999	$17.89	Disposed	45592	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-01	Director Stock Option (right to purchase)	$2.75	M	13000	Disposed	2020-01-02	Common Stock (13000)	Direct

Footnotes

F1: This Form is being filed to report the exercise of a stock option for a total of 13,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 11,001 shares of common stock.